• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用放射性标记血清淀粉样蛋白P成分的研究为体内淀粉样沉积物的周转和消退提供了证据。

Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo.

作者信息

Hawkins P N

机构信息

Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, U.K.

出版信息

Clin Sci (Lond). 1994 Sep;87(3):289-95. doi: 10.1042/cs0870289.

DOI:10.1042/cs0870289
PMID:7955904
Abstract
  1. Quantitative scintigraphic and turnover studies, utilizing the specific binding affinity of serum amyloid P component for amyloid fibrils, have been developed as a tool for evaluating amyloid deposits in vivo. 2. Serial studies in over 300 patients have shown characteristic, diagnostic tissue distributions of amyloid in different types of amyloidosis. There is generally a poor correlation between quantity of amyloid and associated organ dysfunction. 3. Contrary to previous expectations, regression of amyloid has been demonstrated systematically for the first time: AA, AL and variant transthyretin-associated amyloid deposits often regress rapidly, and sometimes completely, if the supply of fibril protein precursors is substantially reduced.
摘要
  1. 利用血清淀粉样蛋白P成分对淀粉样纤维的特异性结合亲和力进行的定量闪烁扫描和周转率研究,已被开发为一种在体内评估淀粉样沉积物的工具。2. 对300多名患者的系列研究表明,不同类型淀粉样变性中淀粉样蛋白具有特征性的、可诊断的组织分布。淀粉样蛋白的数量与相关器官功能障碍之间通常相关性较差。3. 与先前的预期相反,首次系统地证明了淀粉样蛋白的消退:如果纤维蛋白前体的供应大幅减少,AA、AL和变异甲状腺素转运蛋白相关的淀粉样沉积物通常会迅速消退,有时甚至完全消退。

相似文献

1
Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo.使用放射性标记血清淀粉样蛋白P成分的研究为体内淀粉样沉积物的周转和消退提供了证据。
Clin Sci (Lond). 1994 Sep;87(3):289-95. doi: 10.1042/cs0870289.
2
Diagnosis and monitoring of amyloidosis.淀粉样变性的诊断与监测。
Baillieres Clin Rheumatol. 1994 Aug;8(3):635-59. doi: 10.1016/s0950-3579(05)80120-7.
3
Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.对系统性AA型和AL型淀粉样变性患者进行碘-123标记血清淀粉样蛋白P成分的动力学研究及临床价值评估。
J Nucl Med. 1998 Apr;39(4):699-706.
4
Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.人体内脏淀粉样沉积物的闪烁扫描定量分析和连续监测为其周转和消退提供了证据。
Q J Med. 1993 Jun;86(6):365-74.
5
Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.与血清淀粉样蛋白A蛋白循环浓度相关的AA型淀粉样变性中的淀粉样蛋白负荷及临床结局
Lancet. 2001 Jul 7;358(9275):24-9. doi: 10.1016/S0140-6736(00)05252-1.
6
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.血清淀粉样蛋白P成分闪烁扫描术用于淀粉样变性的诊断和监测。
Curr Opin Nephrol Hypertens. 2002 Nov;11(6):649-55. doi: 10.1097/00041552-200211000-00013.
7
Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis.系统性淀粉样变性中使用碘-131标记血清淀粉样蛋白P成分的闪烁成像和周转率研究。
Eur J Nucl Med. 1998 Jul;25(7):701-8. doi: 10.1007/s002590050272.
8
Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.123I标记的血清淀粉样蛋白P成分闪烁扫描术在淀粉样变性患者中的诊断效能
Am J Med. 2006 Apr;119(4):355.e15-24. doi: 10.1016/j.amjmed.2005.08.043.
9
A primed state exists in vivo following histological regression of amyloidosis.在淀粉样变性的组织学消退后,体内存在一种预激发状态。
Clin Exp Immunol. 1990 Aug;81(2):325-8. doi: 10.1111/j.1365-2249.1990.tb03339.x.
10
Micro-imaging of amyloid in mice.小鼠淀粉样蛋白的微观成像。
Methods Enzymol. 2006;412:161-82. doi: 10.1016/S0076-6879(06)12011-X.

引用本文的文献

1
Evolution of Disease-modifying Therapy for Transthyretin Cardiac Amyloidosis.转甲状腺素蛋白心脏淀粉样变疾病修饰疗法的演变
Heart Int. 2024 Jun 27;18(1):30-37. doi: 10.17925/HI.2024.18.1.5. eCollection 2024.
2
Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping.心脏磁共振衍生细胞外容积测绘追踪系统性 AL 淀粉样变多器官治疗反应。
JACC Cardiovasc Imaging. 2023 Aug;16(8):1038-1052. doi: 10.1016/j.jcmg.2023.02.019. Epub 2023 May 10.
3
Comparative Proteomic Analysis of Serum from Pigs Experimentally Infected with , and .
对实验感染[具体病毒名称缺失]、[具体病毒名称缺失]和[具体病毒名称缺失]的猪血清进行的比较蛋白质组学分析
Pathogens. 2020 Jan 11;9(1):55. doi: 10.3390/pathogens9010055.
4
Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.用于临床的药物级人五聚素、血清淀粉样蛋白 P 成分和 C 反应蛋白的分离和特性描述。
J Immunol Methods. 2012 Oct 31;384(1-2):92-102. doi: 10.1016/j.jim.2012.07.013. Epub 2012 Jul 31.
5
Amyloid deposition in rheumatoid arthritis of the hip.髋关节类风湿关节炎中的淀粉样沉积。
Rheumatol Int. 2012 Sep;32(9):2645-51. doi: 10.1007/s00296-011-2005-9. Epub 2011 Jul 24.
6
Systemic amyloidosis and the gastrointestinal tract.系统性淀粉样变性与胃肠道
Nat Rev Gastroenterol Hepatol. 2009 Oct;6(10):608-17. doi: 10.1038/nrgastro.2009.147. Epub 2009 Sep 1.
7
Where has secondary amyloid gone?继发性淀粉样变哪里去了?
Ann Rheum Dis. 2000 Aug;59(8):577-9. doi: 10.1136/ard.59.8.577.
8
A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis.一种检测关节炎患者抽吸脂肪组织中淀粉样蛋白A沉积的定量方法。
Ann Rheum Dis. 1999 Feb;58(2):96-102. doi: 10.1136/ard.58.2.96.
9
Amyloidosis and the respiratory tract.淀粉样变性与呼吸道
Thorax. 1999 May;54(5):444-51. doi: 10.1136/thx.54.5.444.
10
The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.系统性淀粉样变性中的肝脏:484例患者123I血清淀粉样蛋白P成分闪烁扫描的见解
Gut. 1998 May;42(5):727-34. doi: 10.1136/gut.42.5.727.